Xoma reported $-4372000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
Agenus AGEN:US USD -41645000 2.92M
Agios Pharmaceuticals AGIO:US USD -86647000 8.29M
Ardelyx ARDX:US USD -21880000 4.34M
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bluebird Bio BLUE:US USD -84781000 22.62M
Celldex Therapeutics CLDX:US USD -27696000 8.7M
Chimerix CMRX:US USD 11.65M 35.09M
Curis CRIS:US USD -12606000 2.46M
Eli Lilly And LLY:US USD 1.84B 159.9M
Emergent Biosolutions EBS:US USD -42000000 30M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
Life Technologies LIFE:US USD -13492000 908K
Macrogenics MGNX:US USD -24955000 16.85M
Novartis NOVN:VX USD 1.95B 219M
Novartis NVS:US USD 1.95B 219M
Pfizer PFE:US USD 5.17B 4.24B
Prothena PRTA:US USD -50332000 7.12M
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Teva Pharmaceutical Industries TEVA:US USD 419M 1.37B
Xoma XOMA:US USD -4372000 395K